4 unknown. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 1 | Unknown 1 |
Follow Renal Impairment: new trials by email Literature Review of Renal Impairment trials Research Report on Renal Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor Isatuximab, Pomalidomide, Dexamethasone - Multiple Myeloma, Renal Impairment | Phase 2 | Unknown | Hellenic Society of Hematology | 108 | 2022-05-01 | 2022-03-28 |
| A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment Isatuximab, Bortezomib, Cyclophosphamide - Multiple Myeloma, Renal Impairment | Phase 2 | Unknown | Hellenic Society of Hematology | 51 | 2022-04-01 | 2022-03-29 |
| CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation delayed, low-dose CNI, BU-CNI, BU-Everolimus - Renal Impairment, Liver Transplantation | Phase 2 / Phase 3 | Unknown | University of Regensburg | 45 | 2011-06-01 | 2011-07-01 |
| Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study Albumin - Renal Impairment, All Cause Mortality | Phase 2 | Unknown | Hospital de Clinicas de Porto Alegre | 43 | 2006-03-01 | 2010-06-07 |
Renal Insufficiency (4) · Blood Protein Disorders (2) · Hematologic Diseases (2) · Multiple Myeloma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Plasma Cell (2) · Paraproteinemias (2)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Kidney Diseases (4) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Cardiovascular Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphoproliferative Disorders (2) · Vascular Diseases (2)
Dexamethasone (2) · isatuximab (2) · Acetaminophen (1) · Albumins (1) · Bortezomib (1) · Cyclophosphamide (1) · Diphenhydramine (1) · Lenalidomide (1) · Ranitidine (1) · Saline Solution (1) · cni protein, Drosophila (1) · pomalidomide (1)
Hellenic Society of Hematology (2) · Hospital de Clinicas de Porto Alegre (1) · University of Regensburg (1)
Greece (2) · Brazil (1) · Germany (1)
Evangelos Terpos, Prof (2) · Alexandre Araujo (1) · Andreas A Schnitzbauer, MD (1) · Gabriela Rossi (1) · Hans J Schlitt, MD (1)